FAIRFIELD, N.J., Dec. 7 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, Inc. announced today that Daniel Glassman, the Company's President and CEO, will be awarded the honorary degree of Doctor of Humane Letters on December 13, 2005 at the Annual Convocation for the New York College of Podiatric Medicine. This honor is in recognition of his commitment and contributions to the specialty of podiatry and to podiatric medical education.
Under Mr. Glassman's leadership, Bradley's Doak Dermatologics subsidiary has shown a strong dedication to the podiatric community. In addition to the Company's support of podiatric professional medical associations at the national, regional, and local levels, Doak has sponsored numerous podiatric medical education programs as well as symposia on diagnosing and treating conditions that manifest in the lower extremities. Through Mr. Glassman's commitment and sense of mission, Doak has made significant contributions to the practice of podiatry and excellence in patient care.
Mr. Glassman stated, "I am deeply gratified that the distinguished New York College of Podiatric Medicine has chosen to name me Doctor of Humane Letters. I recognize that this honor is a reflection of the dedication of each and every Bradley associate who has worked tirelessly to promote the highest standards of physician service, professional medical education and patient care."
Bradley Pharmaceuticals, Inc. was founded in 1985 as a specialty pharmaceutical company marketing to niche physician specialties in the U.S. and 38 international markets. Bradley's success is based on the strategy of Acquire, Enhance and Grow. Bradley Acquires non-strategic brands, Enhances these brands with line extensions and improved formulations and Grows the products through promotion, advertising and selling activities to optimize life cycle management. Bradley Pharmaceuticals is comprised of Doak Dermatologics, specializing in topical therapies for dermatology and podiatry, and Kenwood Therapeutics, providing gastroenterology, respiratory and other internal medicine brands.
Important announcement:
Daniel Glassman will present at the Raymond James & Associates 27th Annual Institutional Investors Conference, Hyatt Regency Grand Cypress in Orlando, FL, March 5-8th, 2006.
Daniel Glassman will present at the Banc of America Securities LLC, Health Care Conference 2006, to be held at The Four Seasons Hotel in Las Vegas, NV, May 16-18th, 2006.
Please visit Bradley Pharmaceuticals web site at: http://www.bradpharm.com.
Bradley Pharmaceuticals common stock is listed on the NYSE under the symbol BDY.
Bradley Pharmaceuticals, Inc.CONTACT: Anthony Griffo, Investor Relations of Bradley Pharmaceuticals,Inc., +1-973-882-1505, ext. 313
Web site: http://www.bradpharm.com/
